<DOC>
	<DOCNO>NCT01486758</DOCNO>
	<brief_summary>This trial proof-of-concept pilot study aim investigate biologic clinical effect early azithromycin treatment child hospitalize Respiratory Syncytial Virus ( RSV ) bronchiolitis . HYPOTHESES In infant hospitalize RSV bronchiolitis , azithromycin therapy ( compare placebo ) result : 1 . Decreased concentration inflammatory mediator ( IL-8 primary outcome ) serum nasal wash measure day 8 randomization . 2 . A small proportion participant recurrent ( â‰¥2 ) wheeze episodes week 3-52 following randomization .</brief_summary>
	<brief_title>Azithromycin Prevent Wheezing Following Severe Respiratory Syncytial Virus ( RSV ) Bronchiolitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Respiratory Sounds</mesh_term>
	<criteria>1 . Age : 118 month . 2 . Hospitalization first episode RSV bronchiolitis : Confirmed RSV infection positive nasal swab result ( viral culture and/or direct antigen detection ) SLCH virology lab ; AND At least two follow symptoms/signs bronchiolitis : respiratory rate great 40 breaths/minute ; cough ; wheeze ; audible rale , crackle , and/or rhonchus ; paradoxical chest movement ( retraction ) . 3 . Duration respiratory symptom initiation symptom admission 5 day less . Time admission define time child see ED visit lead hospitalization . 4 . Randomization perform within 48 hour time admission ( defined time first set vital sign obtain floor ) . 5 . Willingness provide informed consent child 's parent guardian 1 . Prematurity ( gestational age &lt; 36 week ) . 2 . Presence history significant disease ( CNS , lung , cardiac , renal , GI , hepatic disease , hematologic , endocrine immune disease ) . Children atopic dermatitis exclude study . 3 . Clinically significant gastroesophageal reflux currently treat daily antireflux medication ( anti H2 PPI ) . 4 . The child significant developmental delay/failure thrive , define weight &lt; 3 % age gender . 5 . History previous ( current episode ) wheeze previous treatment albuterol . 6 . Treatment ( past present ) corticosteroid ( systemic inhale ) and/or montelukast . 7 . Treatment antibiotic past 2 week . 8 . Treatment Macrolide antibiotic ( Azithromycin , clarithromycin erythromycin ) past 4 week . 9 . Current treatment daily medication ( albuterol , vitamins nutritional supplement ) . 10 . Participation another clinical trial . 11 . Evidence family may unreliable nonadherent , may move clinical center area trial completion . 12 . Contraindication use azithromycin macrolide antibiotic .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>